tiprankstipranks
Trending News
More News >
International Flavors & Fragrances (IFF)
:IFF
Advertisement

International Flavors & Fragrances (IFF) AI Stock Analysis

Compare
744 Followers

Top Page

IFF

International Flavors & Fragrances

(NYSE:IFF)

Rating:50Neutral
Price Target:
$65.00
â–¼(-1.71% Downside)
IFF's overall stock score is primarily impacted by its financial challenges, including declining revenue and profitability. Technical analysis indicates bearish momentum, and valuation metrics are concerning with a negative P/E ratio. The earnings call provides some optimism with strategic improvements and growth in key segments, but ongoing challenges in certain areas temper the outlook.
Positive Factors
Financial Performance
IFF has delivered six sequential quarterly beats compared to consensus, indicating strong performance and consistency.
Strategic Initiatives
New strategic initiatives include divestments and the reinstatement of share repurchases.
Valuation
IFF is trading at a significant discount of more than 25% to 2025 PER, presenting an opportunity to re-enter the shares.
Negative Factors
Competitive Pressure
The more commoditized Fragrance Ingredients business is facing increasing competition.
Earnings Estimate
Earnings estimates have been reset lower due to management expectations and reports of slowing consumer spending, impacting growth forecasts.
Growth Forecast
The slowdown in projected organic growth and some margins pressures are becoming more pronounced.

International Flavors & Fragrances (IFF) vs. SPDR S&P 500 ETF (SPY)

International Flavors & Fragrances Business Overview & Revenue Model

Company DescriptionInternational Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
How the Company Makes MoneyIFF generates revenue through the sale of its flavor and fragrance products to a variety of industries, including food and beverage, personal care, household care, and more. The company operates on a B2B model, supplying customized solutions that often include proprietary ingredients, which allows for higher margins. Key revenue streams include long-term contracts with major consumer goods companies, which provide stable and recurring income, as well as project-based work for smaller clients. Significant partnerships with leading brands in various sectors further enhance IFF's market position and contribute to its earnings, alongside ongoing investments in innovation and sustainability initiatives that cater to evolving consumer preferences.

International Flavors & Fragrances Key Performance Indicators (KPIs)

Any
Any
Adjusted Operating EBITDA by Segment
Adjusted Operating EBITDA by Segment
Shows the profitability of each segment after removing non-recurring items, offering a clearer view of operational efficiency and segment performance.
Chart InsightsIFF's Taste segment has rebounded in 2025 after a long period of inactivity, while Nourish has ceased contributing to EBITDA, likely due to strategic divestitures. Health & Biosciences faces ongoing challenges, with expected negative growth due to market pressures in North America and China. Despite these hurdles, IFF's strategic divestitures and share repurchase program signal a focus on strengthening its core operations and financial health, aiming for a mid-teens EBITDA margin in food ingredients. Investors should watch for the impact of these strategic shifts on future performance.
Data provided by:Main Street Data

International Flavors & Fragrances Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: -6.36%|
Next Earnings Date:Nov 10, 2025
Earnings Call Sentiment Neutral
IFF's second quarter results demonstrate progress in strengthening financial positions and achieving growth in key segments such as Taste and Food Ingredients. However, challenges remain in Health & Biosciences and Fragrance Ingredients due to market and competitive pressures. While the company is taking steps to address these issues and has confidence in future innovation pipelines, the outlook for the second half of 2025 is cautious due to expected market softness and challenging comparisons.
Q2-2025 Updates
Positive Updates
Financial Position Strengthened
IFF reduced its net debt-to-EBITDA to 2.5x, below the target of less than 3x, marking the first time since 2018 it has been below this level.
Solid Sales and EBITDA Growth
Achieved 3% sales growth and 7% adjusted operating EBITDA growth in the first half of 2025.
Successful Divestitures
Completed divestitures of Pharma Solutions and Nitrocellulose businesses, which helped reduce leverage and refocus the portfolio.
Share Repurchase Authorization
Announced a new $500 million share repurchase authorization, reflecting confidence in the future of IFF.
Taste Segment Growth
Taste segment achieved a 6% increase in sales, with strong performance in Latin America and the EMEA region.
Food Ingredients Profitability Improvement
Food Ingredients segment delivered a 21% increase in adjusted operating EBITDA, driven by productivity and favorable net pricing.
Negative Updates
Health & Biosciences Challenges
Expecting negative growth in H&B in Q3 due to strong comps and market softness, particularly in health-related products.
Fragrance Ingredients Underperformance
Fragrance Ingredients segment faced declines due to low-cost competition and pressure on commodity prices.
Market Challenges and Outlook
Facing dynamic macroeconomic environment with pressures like evolving trade policies and weakening consumer demand, projecting challenges in the second half of 2025.
Scent Segment Pressure
Fragrance Ingredients underperformed due to low-cost competition and commodity pressures, expected to continue in the second half.
Currency Impact
Emerging market currencies are creating headwinds, impacting the top-line negatively despite improvements in major currencies like the euro.
Company Guidance
In the IFF Second Quarter 2025 Earnings Conference Call, the company reported a 3% increase in sales, reaching over $2.75 billion, with adjusted operating EBITDA increasing by 6% to $552 million. Key achievements included solid growth across all segments, notably a 6% sales increase in the Taste division and a 21% rise in Pharma Solutions before its divestiture. The company's net debt-to-EBITDA ratio improved to 2.5x, following strategic divestitures and a successful debt tender offering. Despite an increasingly challenging environment, IFF reaffirmed its full-year 2025 guidance, anticipating sales between $10.6 billion to $10.9 billion and adjusted operating EBITDA of $2 billion to $2.15 billion. The company also announced a $500 million share repurchase authorization, highlighting confidence in its future growth and commitment to a balanced capital allocation strategy.

International Flavors & Fragrances Financial Statement Overview

Summary
IFF is facing financial challenges, with declining revenue and profitability impacting its income statement. The balance sheet remains stable with moderate leverage, but profitability issues are evident with a negative ROE. Cash flow generation is weak, with significant declines in free cash flow. The company needs to address operational inefficiencies and improve cash generation to enhance financial health.
Income Statement
45
Neutral
The income statement reveals a challenging period for IFF, with declining revenue and profitability. The TTM data shows a negative net profit margin of -7.31% and an EBIT margin of -4.71%, indicating operational inefficiencies. Revenue growth has been negative, with a -1.09% decline in the TTM, reflecting a downturn in sales. The gross profit margin remains moderate at 34.84%, but the overall profitability is under pressure due to high costs and declining sales.
Balance Sheet
55
Neutral
IFF's balance sheet shows a moderate debt-to-equity ratio of 0.75 in the TTM, suggesting a balanced approach to leveraging. However, the return on equity is negative at -5.96%, indicating that the company is not generating sufficient returns on shareholder investments. The equity ratio stands at 55.12%, reflecting a stable capital structure, but the negative ROE highlights underlying profitability issues.
Cash Flow
50
Neutral
The cash flow statement indicates a significant decline in free cash flow, with a -57.82% growth rate in the TTM. The operating cash flow to net income ratio is 0.24, suggesting that cash generation from operations is not robust enough to cover net losses. The free cash flow to net income ratio is 0.52, indicating some ability to generate cash relative to net income, but overall cash flow health is weak.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.30B11.48B11.48B12.44B11.66B5.08B
Gross Profit4.10B4.12B3.68B4.15B3.73B2.09B
EBITDA808.00M1.60B-996.00M-110.00M1.80B897.67M
Net Income-393.00M243.00M-2.56B-1.84B268.00M365.00M
Balance Sheet
Total Assets26.12B28.67B30.98B35.52B39.66B13.56B
Cash, Cash Equivalents and Short-Term Investments816.00M469.00M709.00M493.00M715.00M656.84M
Total Debt6.85B9.62B10.82B11.74B12.20B4.73B
Total Liabilities11.69B14.76B16.34B17.78B18.44B7.14B
Stockholders Equity14.40B13.88B14.61B17.66B21.08B6.31B
Cash Flow
Free Cash Flow240.00M607.00M936.00M-161.00M1.04B522.30M
Operating Cash Flow889.00M1.07B1.44B345.00M1.44B714.10M
Investing Cash Flow2.13B326.00M574.00M745.00M-18.00M-187.46M
Financing Cash Flow-2.86B-1.61B-1.85B-1.18B-1.30B-511.57M

International Flavors & Fragrances Technical Analysis

Technical Analysis Sentiment
Negative
Last Price66.13
Price Trends
50DMA
72.53
Negative
100DMA
73.89
Negative
200DMA
79.06
Negative
Market Momentum
MACD
-2.29
Negative
RSI
37.70
Neutral
STOCH
84.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IFF, the sentiment is Negative. The current price of 66.13 is below the 20-day moving average (MA) of 68.15, below the 50-day MA of 72.53, and below the 200-day MA of 79.06, indicating a bearish trend. The MACD of -2.29 indicates Negative momentum. The RSI at 37.70 is Neutral, neither overbought nor oversold. The STOCH value of 84.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IFF.

International Flavors & Fragrances Risk Analysis

International Flavors & Fragrances disclosed 30 risk factors in its most recent earnings report. International Flavors & Fragrances reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

International Flavors & Fragrances Peers Comparison

Overall Rating
UnderperformOutperform
Sector (43)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$16.21B23.5925.42%1.64%0.51%17.21%
75
Outperform
$4.83B35.8612.18%1.44%4.95%53.63%
65
Neutral
$7.66B9.3714.52%4.95%1.60%-3.97%
63
Neutral
$25.47B20.0116.88%2.45%-10.59%-7.79%
58
Neutral
$17.31B70.601.08%9.74%-14.12%-89.22%
50
Neutral
$16.87B83.39-2.74%2.42%-0.07%83.36%
43
Neutral
C$909.73M-8.580.05%2.69%23.40%-43.48%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IFF
International Flavors & Fragrances
66.13
-32.38
-32.87%
EMN
Eastman Chemical
66.01
-29.22
-30.68%
LYB
LyondellBasell
55.47
-34.18
-38.13%
PPG
PPG Industries
111.57
-10.61
-8.68%
RPM
RPM International
124.34
12.00
10.68%
SXT
Sensient Technologies
114.37
41.64
57.25%

International Flavors & Fragrances Corporate Events

Executive/Board Changes
IFF Appoints New Chief Accounting Officer
Neutral
Aug 7, 2025

On August 7, 2025, International Flavors & Fragrances Inc. announced the appointment of Marc Birenkrant as the new Controller & Chief Accounting Officer, effective August 10, 2025. With over 30 years of experience in finance and accounting, Birenkrant has been with IFF since 2008 and has held several leadership roles. He replaces Beril Yildiz, who will leave the company on December 31, 2025, ensuring a smooth transition of responsibilities. This leadership change is significant for IFF’s financial operations and may impact its strategic positioning within the industry.

M&A TransactionsStock BuybackBusiness Operations and StrategyFinancial Disclosures
IFF Announces $500 Million Share Repurchase Program
Positive
Aug 5, 2025

On August 5, 2025, IFF announced a $500 million share repurchase program, reflecting confidence in its long-term value and marking a key milestone in its capital allocation strategy. The company reported second-quarter 2025 financial results with net sales of $2.76 billion, a 4% decrease from the previous year, but saw a 3% increase in currency-neutral sales. IFF also reduced leverage to 2.5x, reaffirmed its full-year financial guidance, and announced the divestiture of its soy crush, concentrates, and lecithin business as part of its strategy to focus on more value-added offerings.

Executive/Board Changes
International Flavors & Fragrances Appoints New Board Members
Neutral
Jul 30, 2025

On July 29, 2025, International Flavors & Fragrances Inc. announced the appointment of Jesus Mantas and Paul Fribourg to its board of directors. Mantas, with a strong background in business transformation and consulting, joins the Audit and Innovation Committees, while Fribourg, an experienced leader in agribusiness and investment, joins the Transaction Committee. Both are recognized as independent directors under NYSE regulations, with no material interest in transactions exceeding $120,000 involving the company.

Executive/Board Changes
International Flavors & Fragrances Appoints Virginia Drosos to Board
Positive
Jun 9, 2025

On June 9, 2025, International Flavors & Fragrances Inc. announced the appointment of Ms. Virginia Drosos to its board of directors, effective June 16, 2025. Ms. Drosos, with a strong background in leadership roles at Signet Jewelers Ltd., Assurex Health, Inc., and Procter & Gamble, brings extensive experience in digital transformation, revenue growth, and innovation to the company. Her appointment is expected to strengthen the board’s capabilities in audit, human capital, compensation, and innovation, potentially impacting the company’s strategic direction and stakeholder interests positively.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025